Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy
Tóm tắt
Patients with HIV/AIDS on Antiretroviral Therapy (ART) suffer from physical, psychological and spiritual problems. Despite international policy explicitly stating that a multidimensional approach such as palliative care should be delivered throughout the disease trajectory and alongside treatment, the effectiveness of this approach has not been tested in ART-experienced populations. This mixed methods study uses a Randomised Controlled Trial (RCT) to test the null hypothesis that receipt of palliative care in addition to standard HIV care does not affect pain compared to standard care alone. An additional qualitative component will explore the mechanism of action and participant experience. The sample size is designed to detect a statistically significant decrease in reported pain, determined by a two tailed test and a p value of ≤0.05. Recruited patients will be adults on ART for more than one month, who report significant pain or symptoms which have lasted for more than two weeks (as measured by the African Palliative Care Association (APCA) African Palliative Outcome Scale (POS)). The intervention under trial is palliative care delivered by an existing HIV facility nurse trained to a set standard. Following an initial pilot the study will be delivered in two African countries, using two parallel independent Phase III clinical RCTs. Qualitative data will be collected from semi structured interviews and documentation from clinical encounters, to explore the experience of receiving palliative care in this context. The data provided by this study will provide evidence to inform the improvement of outcomes for people living with HIV and on ART in Africa. ClinicalTrials.gov Identifier: NCT01608802
Tài liệu tham khảo
UNAIDS: UNAIDS 2010 global report. 2010, Geneva Switzerland: UNAIDS
Piot P, Coll Seck AM: International response to the HIV/AIDS epidemic: planning for success. Bull World Health Organ. 2001, 79 (12): 1106-1112.
WHO: Rapid advice. Antiretroviral therapy for HIV infection in adults and adolescents. 2009, Geneva: WHO
WHO: Towards universal access scaling up priority HIV/AIDS interventions in the health sector: progress report 2010. 2010, Geneva: WHO Press
Campos LN, Cesar CC, Guimaraes MDC: Quality of life among HIV-infected patients in Brazil after initiation of treatment. Clinics (Sao Paulo). 2009, 64 (9): 867-875.
Fan APC, et al: Quality of life and needs assessment on people living with HIV and AIDS in Malawi. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2011, 23 (3): 287-302.
Willard S, et al: Does “asymptomatic” mean without symptoms for those living with HIV infection?. AIDS Care. 2009, 21 (3): 322-328. 10.1080/09540120802183511.
Harding R, et al: Is antiretroviral therapy associated with symptom prevalence and burden?. Int J STD AIDS. 2006, 17 (6): 400-405. 10.1258/095646206777323409.
Bhengu BR, et al: Symptoms experienced by HIV-infected Individuals on antiretroviral therapy in KwaZulu-Natal, South Africa. Appl Nurs Res. 2011, 24 (1): 1-9. 10.1016/j.apnr.2009.01.001.
Harding R, et al: Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sex Transm Infect. 2010, 86 (7): 520-524. 10.1136/sti.2009.038505.
Braithwaite R, et al: Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV. Value Health. 2008, 11 (5): 975-979. 10.1111/j.1524-4733.2007.00315.x.
de Menezes Padua CA, et al: Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil. Braz J Infect Dis. 2007, 11 (1): 20-26.
Fellay J, et al: Prevalence of adverse events associated with potent antiretroviral treatment: swiss HIV cohort study. Lancet. 2001, 358 (9290): 1322-1327. 10.1016/S0140-6736(01)06413-3.
Johnson MO, et al: Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage. 2005, 29 (2): 193-205. 10.1016/j.jpainsymman.2004.05.005.
Johnson MO, Stallworth T, Neilands TB: The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS Behav. 2003, 7 (2): 109-117. 10.1023/A:1023938023005.
Mannheimer SB, et al: Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis. 2008, 46 (6): 941-945. 10.1086/528859.
McInerney P, Ncama B, Wantland D: Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nurs Health Sci. 2008, 10 (4): 266-272. 10.1111/j.1442-2018.2008.00410.x.
Gibbie T, et al: Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS. Sex Health. 2007, 4 (4): 227-232. 10.1071/SH06062.
Eriksson LE, Bratt GA, Nordstrom G: The two-year impact of first generation protease inhibitor based antiretroviral therapy (PI-ART) on health-related quality of life. Health Qual Life Outcomes. 2005, 3 (32): 1-8.
Collins K, Harding R: Improving HIV management in sub-Saharan Africa: how much palliative care is needed?. AIDS Care. 2007, 19 (10): 1304-1306. 10.1080/09540120701402863.
WHO: WHO definition of palliative care. 2011 04.04.2011]; Available from: http://www.who.int/hiv/topics/palliative/PalliativeCare/en/
Davies E, Higginson IJ: The solid facts. Palliative Care. 2004, Copenhagen: WHO Europe
Selwyn PA, Forstein M: Overcoming the false dichotomy of curative vs palliative care for late-stage HIV/AIDS: “let me live the way I want to live, until I can’t”. JAMA. 2003, 290 (6): 806-814. 10.1001/jama.290.6.806.
Harding R, et al: Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence. Sex Transm Infect. 2005, 81 (1): 5-14. 10.1136/sti.2004.010132.
Harding R: Palliative care in resource-poor settings: fallacies and misapprehensions. J Pain Symptom Manage. 2008, 36 (5): 515-517. 10.1016/j.jpainsymman.2008.04.019.
Gwyther L: Just palliative care? Integrated models of care. J Pain Symptom Manage. 2008, 36 (5): 517-519. 10.1016/j.jpainsymman.2008.06.003.
Selwyn PA: Palliative care and social justice. J Pain Symptom Manage. 2008, 36 (5): 513-515. 10.1016/j.jpainsymman.2008.08.001.
UNAIDS: AIDS: palliative care. Technical update. 2000, Geneva: UNAIDS
Stjernsward J, Foley KM, Ferris FD: The public health strategy for palliative care. J Pain Symptom Manage. 2007, 33 (5): 486-493. 10.1016/j.jpainsymman.2007.02.016.
Harding R, et al: Access and equity in HIV/AIDS palliative care: a review of the evidence and responses. Palliat Med. 2005, 19 (3): 251-258. 10.1191/0269216305pm1005oa.
Protopopescu C, et al: Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. J Antimicrob Chemother. 2009, 64 (3): 599-606. 10.1093/jac/dkp232.
Gonzalez JS, et al: Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 2011, 58 (2): 181-187.
Ekstrand ML, et al: Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. Int Health. 2011, 3 (1): 27-34. 10.1016/j.inhe.2010.11.003.
Simms VM, Higginson IJ, Harding R: What palliative care-related problems Do patients experience at HIV diagnosis? a systematic review of the evidence. J Pain Symptom Manage. 2011, 42 (5): 734-753. 10.1016/j.jpainsymman.2011.02.014.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Pettigrew M: Developing and Evaluating Complex Interventions: The new Medical Research Council guidance. BMJ. 2008, 337: a1655-10.1136/bmj.a1655.
Gwyther L: HPCA clinical guidelines. [pdf] 2006 2008 28.09.2012]; Available from: http://www.hospicepalliativecaresa.co.za/pdf/guidelinedocs/HPCAClinicalGuidelines.pdf
APCA: Standards for providing quality palliative care across africa. 2011 29/08/2012]; Available from: http://www.africanpalliativecare.org/images/stories/pdf/APCA_Standards.pdf
Harding R, et al: PEPFAR public health evaluation-care and support: phase 2 kenya, in PEPFAR public health evaluation – care and support. U. PEPFAR, measure evaluation. 2010, London: PEPFAR Public Health evaluation - Care and Support
Powell RA, et al: Development of the APCA african palliative outcome scale. J Pain Symptom Manage. 2007, 33 (2): 229-232. 10.1016/j.jpainsymman.2006.10.008.
Dumville JC, Torgerson DJ, Hewitt CE: Reporting attrition in randomised controlled trials. BMJ. 2006, 332 (7547): 969-971. 10.1136/bmj.332.7547.969.
Moher D, et al: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010, 340: c869-10.1136/bmj.c869.
Gwatkin DR RS, Johnson K, Pande RP, Wagstaff A: Socioeconomic differences in health, nutrition, and population in ghana, in health nutrition and population. 2003, Ghana: World Bank
Hearn J, Higginson IJ: Evelopment and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative care core audit project advisory group. Qual Health Care. 1999, 8 (4): 219-227. 10.1136/qshc.8.4.219.
Higginson IJ, Donaldson N: Relationship between three palliative care outcome scales. Health Qual Life Outcomes. 2004, 2: 68-10.1186/1477-7525-2-68.
Harding R, et al: Validation of a core outcome measure for palliative care in africa: the APCA african palliative outcome scale. Health Qual Life Outcomes. 2010, 8: 10-10.1186/1477-7525-8-10.
Harding R, et al: Multi-centred mixed-methods PEPFAR HIV care & support public health evaluation: study protocol. BMC Publ Health. 2010, 10: 584-10.1186/1471-2458-10-584.
Bowling A: Measuring disease. 2001, Buckingham: Open University Press
Harding R, et al: Intensity and correlates of multidimensional problems in HIV patients receiving integrated palliative care in sub-Saharan Africa. Sex Transm Infect. 2012, Epub ahead of print
Wu AW, et al: A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Med Care. 1991, 29 (8): 786-798. 10.1097/00005650-199108000-00011.
Mast TC, et al: Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care. 2004, 16 (1): 81-94. 10.1080/09540120310001633994.
Epino HM, et al: Reliability and construct validity of three health-related self-report scales in HIV-positive adults in rural Rwanda. AIDS Care. 2012, Epub ahead of print
Taylor TN, et al: Reliability and validity of two HIV/AIDS-specific quality of life instruments adapted for use in HIV-positive Zimbabweans. AIDS Care. 2009, 21 (5): 598-607. 10.1080/09540120802302574.
Stangl AL, et al: Measuring quality of life in rural uganda: reliability and validity of summary scores from the medical outcomes study HIV health survey (MOS-HIV). Qual Life Res. 2011, 21 (9): 1655-1663.
Goldberg D, Williams P: A user’s guide to the general health questionnaire. 1991, Windsor: NFER Nelson
Goldberg DP, et al: A comparison of two psychiatric screening tests. Br J Psychiatry. 1976, 129: 61-67. 10.1192/bjp.129.1.61.
Abubakar A, Fischer R: The factor structure of the 12-item general health questionnaire in a literate kenyan population. Stress Heal. 2011, 28 (3): 248-254.
Sherr L, et al: Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010, 22 (8): 939-945. 10.1080/09540121.2010.482126.
Gomes B, et al: Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study. BMC Cancer. 2010, 10: 400-10.1186/1471-2407-10-400.
McCrone P: Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson’s disease, and dementia. J Pain Symptom Manage. 2009, 38 (1): 62-67. 10.1016/j.jpainsymman.2009.04.006.
Harding R, Selman L, Simms V, Penfold S, Agupio G, Dinat N, Downing J, Gwyther L, Ikin B, Mashao T, Mmoledi K, Sebuyira LM, Moll T, Mwangi-Powell F, Namisango E, Powell RA, Walkey F, Higginson IJ, Siegert R: How to analyse palliative care outcome data for patients in sub-Saharan Africa: an international multicentred factor analytic examination of the APCA African POS. J Pain Symptom Manage. 2012, In press
Pope CZS, Mays N: Analysing qualitative data. Br Med J. 2000, 320: 114-116. 10.1136/bmj.320.7227.114.
Creswell JW, Miller DL: Determining validity in qualitative inquiry. Theory Into Practice. 2000, 39 (3): 124-130. 10.1207/s15430421tip3903_2.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/288/prepub